See: Merck, Iowa firm will make and test an Ebola vaccine
It's stuff that was just sitting on the shelf because there was no profit in the virus-shredding technique.
"Ebb in Ebola can complicate testing of drugs" by Andrew Pollack, New York Times January 10, 2015
NEW YORK — A meeting Thursday of public health officials, pharmaceutical executives, and others to discuss the plans for testing vaccines in Liberia, Guinea, and Sierra Leone.
The epidemic has sickened about 21,000 people and killed more than 8,000 of them, the World Health Organization said this week, but there are signs that the epidemic may be coming under control as more treatment centers are built and safer burial practices are used.
Still, the evidence is far from conclusive, and experts are mindful that the outbreak surged again last year after authorities thought it was ebbing....
Vaccines, vaccines, vaccine, vaccinate.
If the epidemic continues to ebb, it may be too late for the vaccines to make a difference in this outbreak....
The two vaccines that are most advanced in testing are being developed by GlaxoSmithKline and Merck.
Another ancillary benefit to the fraud and hoax.
The Glaxo vaccine is being developed with the National Institutes of Health; Merck’s was originally developed by the Public Health Agency of Canada and licensed to a small Iowa company, NewLink Genetics, which in turn transferred development to Merck.
Testing of the Merck vaccine at a hospital in Switzerland was suspended in December after a number of patients developed pain in the joints of their fingers and toes. Testing resumed this week using a lower dose. Kieny said the pain was generally transient and mild and “not of sufficient concern to stop the development of this vaccine.”
More poisons to be pumped into you.
A third vaccine, being developed by Johnson & Johnson, began early safety testing in volunteers this month. That company is also planning tests in West Africa.
There has been debate over how to conduct the studies. Some experts say that testing the vaccines against a placebo would be the surest way to determine whether they work. Others counter that it would be unethical to administer a placebo during a deadly epidemic.
The trials will cover all the approaches, with different designs in each country....
--more--"
“It’s very urgent that we get into the field very quickly to test the vaccines.”
See: As clock ticks, Cambridge lab hunts for Ebola answers
Ritual Circumcision Linked to Increased Risk of Autism in Young Boys
That was a relatively new discovery.
Maybe you would like to take a shot at this "conspiracy" theory?
